Our Leadership

I fell in love with this place nearly 20 years ago because it reminded me of a premier venture capital firm. I draw this analogy because Damon Runyon has been associated with almost every breakthrough in cancer research despite the fact that we only grant around $18-20 million a year - tiny player, enormous impact."

CHAIR
Andrew S. Rachleff

Palo Alto, California

* Indicates member serves on the Scientific Committee

Vice Chair, Scientific Programs

William G. Kaelin, Jr., MD*
Sidney Farber Professor of Medicine
Dana-Farber Cancer Institute and
Harvard Medical School
Howard Hughes Medical Institute Investigator
Boston, Massachusetts

Treasurer

Lawrence W. Cohen
Founder, Partner and CEO
Seven Bridges Advisors, LLC
New York, New York

Secretary

Deborah J. Coleman
Boston, Massachusetts

Receiving a Damon Runyon Fellowship had a tremendous impact on my scientific career. I also have been fortunate to mentor new Damon Runyon scientists in my lab who have gone on to have exemplary independent careers. Damon Runyon builds generations of scientific leaders and mentors.”

Elaine V. Fuchs, PhD

(Damon Runyon Fellow ‘77-‘79)

Carlos L. Arteaga, MD*
Director of the Harold C. Simmons Comprehensive Cancer Center
Associate Dean of Oncology Programs
Professor of Medicine
The Lisa K. Simmons Distinguished Chair in Comprehensive Oncology
University of Texas Southwestern Medical Center
Dallas, Texas

David M. Beirne
General Partner
X10 Capital
San Francisco, California

Melissa L. Cohn
Regional Vice President
William Raveis Mortgage LLC
Delray Beach, FL

Deborah J. Coleman*
Boston, Massachusetts

Robyn Coles
President
TRATE Properties LLC
Boston, Massachusetts

Gary E. Erlbaum
President
Greentree Properties
Ardmore, Pennsylvania

Buck French
General Partner
X10 Capital
San Francisco, California

Elaine V. Fuchs, PhD*
Head, Laboratory of Mammalian Cell Biology and Development
Rebecca C. Lancefield Professor
The Rockefeller University
Howard Hughes Medical Institute Investigator
New York, New York

Levi A. Garraway,
MD, PhD*
Executive Vice President
Chief Medical Officer and Head of Product Development
Genentech/Roche, Inc.
South San Francisco, California

Richard B. Gaynor, MD*
President and Chief of Research and Development
BioNTech US
Cambridge, Massachusetts

Erica Evans Gioffre
Head of Client Engagement
Hirtle, Callahan & Co.

Todd R. Golub, MD*
Director and Founding Core Institute Member
Broad Institute of MIT and Harvard
Charles A. Dana Investigator in Human Cancer Genetics
Dana-Farber Cancer Institute
Professor of Pediatrics
Harvard Medical School
Cambridge, Massachusetts

Damon Runyon is one of the most successful and impactful organizations when it comes to support of the next generation of leaders in cancer research. Our ability to advance the understanding and treatment of cancer depends on the intellectual creativity and firepower of the people doing the research, so I wanted to be a part of ensuring that this organization can continue and grow its remarkable impact.”

Levi A. Garraway, MD, PhD

David A. Gordon, PhD
Strategist
Bridgewater Associates
Westport, CT

Scott Greenstein
President and Chief Content Officer
SiriusXM
New York, New York

Richard Hoffman
Partner
Goodwin Proctor LLP
Boston, Massachusetts

Steven A. Kandarian
Chairman, President and Chief Executive Officer (Retired)
MetLife, Inc
North Palm Beach, Florida

Gabrielle Layton, PhD
Palo Alto, California

Gerald M. Marshall
President & CEO, Netrality Data Centers
Chairman & CEO, Amerimar Enterprises, Inc.
Miami Beach, FL

Sanford W. Morhouse, Esq.
Of Counsel
Schulte Roth & Zabel LLP
New York, New York

Richard J. O’Reilly, MD*
Claire L. Tow Chair, Pediatric Oncology Research
Memorial Sloan Kettering Cancer Center
New York, New York

Joseph Pearlberg, MD, PhD
Vice President of Scientific Affairs, Therapeutics
Deerfield Management Company
New York, New York

Lori J. Pierce, MD*
Professor, Radiation Oncology
University of Michigan
Rogel Cancer Center
Ann Arbor, Michigan

Adam R. Schwartz
Co-Managing Partner
TPG Angelo Gordon
New York, NY

Michael V. Seiden, MD, PhD*
Chief Executive Officer and Co-founder
Gladius Therapeutics
The Woodlands, Texas

Nancy Simonian, MD*
Chief Executive Officer (Retired)
Syros Pharmaceuticals, Inc.
Cambridge, Massachusetts

Amoolya Singh, PhD
Chief Technology Officer
Delfi Diagnostics
Palo Alto, CA and Baltimore, MD

Cynthia Sulzberger
Wellington, Florida

Judy C. Swanson
Hillsborough, California

Peter Van Camp
Executive Chairman
Equinix, Inc.
Redwood City, California

James A. Wells, PhD*
Professor, Department of Pharmaceutical Chemistry
University of California, San Francisco
San Francisco, California

Yung S. Lie, PhD
President and Chief Executive Officer
Damon Runyon Cancer Research Foundation
New York, New York